Price Alert

Biogen Inc. (BIIB)

NASDAQ: BIIB · Real-Time Price · USD

159.88

4.63 (2.98%)

At close: Oct 03, 2025, 3:59 PM

159.00

-0.55%

After-hours: Oct 03, 2025, 07:58 PM EDT

Biogen Statistics

Share Statistics

Biogen has 146.61M shares outstanding. The number of shares has increased by 0.61% in one year.

Shares Outstanding	146.61M
Shares Change (YoY)	0.61%
Shares Change (QoQ)	0.06%
Owned by Institutions (%)	84.17%
Shares Floating	146.23M
Failed to Deliver (FTD) Shares	100
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 5.13M, so 3.5% of the outstanding shares have been sold short.

Short Interest	5.13M
Short % of Shares Out	3.5%
Short % of Float	4.52%
Short Ratio (days to cover)	3.01

Valuation Ratios

The PE ratio is 13.65 and the forward PE ratio is 9.81. Biogen's PEG ratio is 0.34.

PE Ratio	13.65
Forward PE	9.81
PS Ratio	2.3
Forward PS	2.5
PB Ratio	1.33
P/FCF Ratio	8.86
PEG Ratio	0.34

Financial Ratio History

Enterprise Valuation

Biogen has an Enterprise Value (EV) of 26.54B.

EV / Sales	2.74
EV / EBITDA	9.38
EV / EBIT	9.23
EV / FCF	10.55

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.4.

Current Ratio	1.35
Quick Ratio	0.9
Debt / Equity	0.4
Debt / EBITDA	2.34
Debt / FCF	2.64
Interest Coverage	8.86

Financial Efficiency

Return on Equity is 9.76% and Return on Invested Capital is 7.83%.

Return on Equity	9.76%
Return on Assets	5.82%
Return on Invested Capital	7.83%
Revenue Per Employee	$1.27M
Profits Per Employee	$214.62K
Employee Count	7,605
Asset Turnover	0.34
Inventory Turnover	0.94

Taxes

Income Tax	273.8M
Effective Tax Rate	14.37%

Stock Price Statistics

The stock price has increased by -13.89% in the last 52 weeks. The beta is 0.12, so Biogen's price volatility has been higher than the market average.

Beta	0.12
52-Week Price Change	-13.89%
50-Day Moving Average	138
200-Day Moving Average	135.34
Relative Strength Index (RSI)	74.25
Average Volume (20 Days)	1,559,288

Income Statement

In the last 12 months, Biogen had revenue of 9.68B and earned 1.63B in profits. Earnings per share was 11.2.

Revenue	9.68B
Gross Profit	7.37B
Operating Income	2.22B
Net Income	1.63B
EBITDA	2.83B
EBIT	2.16B
Earnings Per Share (EPS)	11.2

Full Income Statement

Balance Sheet

The company has 2.38B in cash and 6.63B in debt, giving a net cash position of -4.26B.

Cash & Cash Equivalents	2.38B
Total Debt	6.63B
Net Cash	-4.26B
Retained Earnings	19.26B
Total Assets	28.33B
Working Capital	4.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.88B and capital expenditures -359.8M, giving a free cash flow of 2.52B.

Operating Cash Flow	2.88B
Capital Expenditures	-359.8M
Free Cash Flow	2.52B
FCF Per Share	17.27

Full Cash Flow Statement

Margins

Gross margin is 76.12%, with operating and profit margins of 22.93% and 16.87%.

Gross Margin	76.12%
Operating Margin	22.93%
Pretax Margin	19.7%
Profit Margin	16.87%
EBITDA Margin	29.24%
EBIT Margin	22.93%
FCF Margin	26%

Dividends & Yields

BIIB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	7.33%
FCF Yield	11.29%

Dividend Details

Analyst Forecast

The average price target for BIIB is $185, which is 15.7% higher than the current price. The consensus rating is "Hold".

Price Target	$185
Price Target Difference	15.7%
Analyst Consensus	Hold
Analyst Count	24

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$56
Lynch Upside	-64.97%
Graham Number	170.05
Graham Upside	6.36%

Stock Splits

The last stock split was on Jan 18, 2001. It was a forward split with a ratio of 3:1.

Last Split Date	Jan 18, 2001
Split Type	forward
Split Ratio	3:1

Scores

Altman Z-Score	2.91
Piotroski F-Score	6